看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
6 @2 |2 ~& c, g5 l. a6 `
4 P' M3 d: B; j/ L8 S/ c
5 Q) t7 W# C8 j, x1 U7 p5 vCurrently available feasibility data for possible combination strategies. 9 P# V6 D; T: j7 c3 L# A. q
————————————————————————————————: N, H2 S% {' [! v
Combination Feasibility according to preliminary data E; \6 A# O. k' O: Q, ^0 W% e
——————————————————————————————————0 m. ^$ o. h }
Bevacizumab + sorafenib Yes, reduced dose
# Z% m3 L4 V5 d- D4 NBevacizumab + sunitinib† No
. V. p P0 G( C9 BBevacizumab + temsirolimus Yes
x3 p' U' G V; f3 P- [Bevacizumab + everolimus Yes
" w+ p _0 n& f% u& ~4 `Sorafenib + sunitinib ? . d7 e+ C2 i5 M' e0 d
Sorafenib + temsirolimus Yes, reduced dose
$ R8 p7 Q6 B# {% V/ H4 uSorafenib + everolimus Yes, reduced dose 7 R) y) Y+ v* j/ z
Sunitinib + temsirolimus† No : I& i7 V2 v8 ], n& h3 ~/ k
Sunitinib + everolimus ? 2 F4 _+ w& E4 g
Temsirolimus + everolimus ? 0 ~ s7 Z: {( B/ `/ n2 d
————————————————————
% G6 C9 y# q- S' p! T2 y: Z x†Led to US FDA warning.
% A2 \: P# E, f9 b# V?: As yet unattempted combination.- i' B' d% N! i
|